Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer.
Mosher CE, Lee S, Addington EL, Park S, Lewson AB, Snyder S, Hirsh AT, Bricker JB, Miller KD, Ballinger TJ, Schneider BP, Storniolo AM, Newton EV, Champion VL, Johns SA. Mosher CE, et al. Among authors: ballinger tj. J Clin Oncol. 2024 Oct 25:JCO2400965. doi: 10.1200/JCO.24.00965. Online ahead of print. J Clin Oncol. 2024. PMID: 39454125
Racial disparities in cascade testing for cancer predisposition genes.
Kassem NM, Althouse SK, Monahan PO, Hayes L, Nielsen SM, Heald B, Esplin ED, Hatchell KE, Ballinger TJ. Kassem NM, et al. Among authors: ballinger tj. Prev Med. 2023 Jul;172:107539. doi: 10.1016/j.ypmed.2023.107539. Epub 2023 May 6. Prev Med. 2023. PMID: 37156429
Discerning the clinical relevance of biomarkers in early stage breast cancer.
Ballinger TJ, Kassem N, Shen F, Jiang G, Smith ML, Railey E, Howell J, White CB, Schneider BP. Ballinger TJ, et al. Breast Cancer Res Treat. 2017 Jul;164(1):89-97. doi: 10.1007/s10549-017-4238-0. Epub 2017 Apr 11. Breast Cancer Res Treat. 2017. PMID: 28401365 Free article.
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
Radovich M, Jiang G, Hancock BA, Chitambar C, Nanda R, Falkson C, Lynce FC, Gallagher C, Isaacs C, Blaya M, Paplomata E, Walling R, Daily K, Mahtani R, Thompson MA, Graham R, Cooper ME, Pavlick DC, Albacker LA, Gregg J, Solzak JP, Chen YH, Bales CL, Cantor E, Shen F, Storniolo AMV, Badve S, Ballinger TJ, Chang CL, Zhong Y, Savran C, Miller KD, Schneider BP. Radovich M, et al. Among authors: ballinger tj. JAMA Oncol. 2020 Sep 1;6(9):1410-1415. doi: 10.1001/jamaoncol.2020.2295. JAMA Oncol. 2020. PMID: 32644110 Free PMC article. Clinical Trial.
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
Tung NM, Robson ME, Ventz S, Santa-Maria CA, Nanda R, Marcom PK, Shah PD, Ballinger TJ, Yang ES, Vinayak S, Melisko M, Brufsky A, DeMeo M, Jenkins C, Domchek S, D'Andrea A, Lin NU, Hughes ME, Carey LA, Wagle N, Wulf GM, Krop IE, Wolff AC, Winer EP, Garber JE. Tung NM, et al. Among authors: ballinger tj. J Clin Oncol. 2020 Dec 20;38(36):4274-4282. doi: 10.1200/JCO.20.02151. Epub 2020 Oct 29. J Clin Oncol. 2020. PMID: 33119476 Clinical Trial.
52 results